Literature DB >> 9107273

Hormone replacement therapy and high incidence of breast cancer between mammographic screens.

V Beral, E Banks, G Reeves, M Wallis.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9107273     DOI： 10.1016/S0140-6736(05)62328-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Menopausal hormone therapy and breast cancer risk: effect modification by body mass through life.

Authors:  Marie Søfteland Sandvei; Lars J Vatten; Elisabeth Krefting Bjelland; Anne Eskild; Solveig Hofvind; Giske Ursin; Signe Opdahl
Journal:  Eur J Epidemiol       Date:  2018-08-06       Impact factor: 8.082

2.  Ospemifene and 4-hydroxyospemifene effectively prevent and treat breast cancer in the MTag.Tg transgenic mouse model.

Authors:  Rebekah A Burich; Neelima Rakesh Mehta; Gregory T Wurz; Jamie Lee McCall; Brittany E Greenberg; Katie E Bell; Stephen M Griffey; Michael W DeGregorio
Journal:  Menopause       Date:  2012-01       Impact factor: 2.953

3.  Breast cancer incidence and overdiagnosis in Catalonia (Spain).

Authors:  Montserrat Martinez-Alonso; Ester Vilaprinyo; Rafael Marcos-Gragera; Montserrat Rue
Journal:  Breast Cancer Res       Date:  2010-08-03       Impact factor: 6.466

4.  Survival from cancer of the breast in women in England and Wales up to 2001.

Authors:  M J Quinn; N Cooper; B Rachet; E Mitry; M P Coleman
Journal:  Br J Cancer       Date:  2008-09-23       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.